GlobeNewswire

D4t4 Solutions Announces Latest Celebrus Release

Dela

Celebrus Advances Customer Data Platform Leadership Further with New Product Features

  • Latest update consolidates Celebrus as enterprise CDP of choice for banking and insurance sectors
  • Integration with Adobe Experience Cloud augments leading digital marketing platform with streaming customer data
  • New Audience Segmentation feature enables advanced targeting of individuals even when they have left a site or app
  • Latest connector supports creation of Custom Audiences in Google and Facebook
  • Hadoop capabilities extended with enhanced support for Hive open-source data warehouse

SUNBURY-ON-THAMES, United Kingdom, April 19, 2018 (GLOBE NEWSWIRE) --  D4t4 Solutions Plc has announced general availability for the latest release of its leading Celebrus Customer Data Platform (CDP).  Continuing its commitment to creating the industry's most advanced unified system for customer data, Version 8 Update 19 delivers a host of new features that broaden the appeal of Celebrus to enterprises focused on deepening customer engagement.

Adobe Experience Cloud integration for optimising digital marketing

Celebrus has for many years enabled a unified stream of customer data for use in marketing applications.  Now though, this capability is being offered to businesses that have invested in the leading marketing cloud applications from Adobe.  Building on the capabilities already available in Adobe Experience Cloud, the Celebrus Adobe Connector streams data to allow Adobe clients to create genuine 1-to-1 personalisation and real-time customer experiences.

Using Celebrus accelerates the availability of customer behaviour data to Adobe Experience Cloud applications and adds customer experience data for complete coverage of customer interactions across channels.

Audience Segmentation for advanced targeting of individuals

Website or mobile app visitors can now be engaged with at any time, whether they are online or not.  Celebrus enables rules to be run that can regularly sweep offline users like those who have abandoned applications, purchasers who have lapsed for a defined period of time or customers who need to complete a transaction by a particular date.  This creates opportunities to segment and target offline users for re-engagement or remarketing initiatives.

Complete control over when and to whom these rules are run allows optimisation of these segmentation activities and identifies actions for each user like sending them a marketing e-mail, creating a lead for outbound contact or adding them to an audience for advert targeting.

Custom Audience Connector for compliant profiling of Google and Facebook users

The advanced profiling features of Celebrus are now being used to enhance the capabilities of leading ad networks, Google and Facebook.  The new Custom Audience Connector for Google or Facebook supports these networks' audience-building features by enhancing their ability to profile users based on common attributes or similar interests.  This profiling capability enables accurate and compliant retargeting and engagement of customers or can be used to build lookalike audiences for customer acquisition and brand awareness campaigns.

Celebrus not only provides first-party compliant data to enable this feature, overcoming any privacy or permissions concerns that may exist, but it also enables this capability in real-time as well as orchestrating adverts with existing DMPs for the most immediate, accurate and effective campaigns.

Backing for open-source analytics extended with support for Apache Hive

The Celebrus Hadoop Data Loader has been hugely beneficial to clients needing to consume data at scale for advanced customer analytics.  Now this capability has been extended by enabling the creation of tables for Apache Hive data warehouse users, accelerating and simplifying the landing of data into that environment.

This feature speeds up the availability of Celebrus data for data science and analytics initiatives, enabling quicker customer insight and availability of data for marketing applications.

Peter Kear, CEO of D4t4 Solutions Plc, said: "The Customer Data Platform is becoming a mainstream requirement for customer-centric businesses. Sophisticated enterprises are recognising that the success of their customer relationships depends on their ability to unify data from across channels and activate it for use in multiple business applications.  Celebrus captures the very best GDPR-compliant customer data, making it available for marketers, analysts, data scientists and insight experts to drive value throughout their organisations.  I am proud that the latest developments to Celebrus enhance our leadership in this fast-growing space and extend our clients' capacity to operationalise their data for mutually-profitable customer relationships."

The latest version of the Celebrus Customer Data Platform, Version 8 Update 19, is available immediately for new and existing Celebrus clients.

About Celebrus

Celebrus (celebrus.d4t4solutions.com) is the Customer Data Platform from D4t4 Solutions Plc.  Celebrus captures the market's most complete picture of customer behaviour and experience, creating events and profiles in real-time for 1-to-1 personalisation and streaming analytics.  Celebrus is quick and easy to deploy and connects to industry-standard data applications for customer insight and engagement.  Celebrus also gives clients complete control by enabling best-in-class privacy compliance and flexible options for hosting data on-premise or securely in the cloud.

Celebrus is used by global businesses in banking, insurance, retail, travel, automotive and telco industries, collaborating with leading industry partners to drive rapid transformation in customer engagement programmes.

D4t4 Solutions (www.d4t4solutions.com) is ALL ABOUT THE DATA, providing comprehensive products and services that drive value from clients' data assets.  D4t4 Solutions was established in 1985 and is listed on the AIM market of the London Stock Exchange (stock code: D4T4).

Media Contacts

Matthew Tod                                                   
D4t4 Solutions Plc                                         
Tel: +44 (0)1932 893333                             
E-mail: matthew.tod@d4t4solutions.com       

David Hetling
D4t4 Solutions Plc
Tel: +44 (0)1932 893386
E-mail: david.hetling@d4t4solutions.com

This information is provided by RNS
The company news service from the London Stock Exchange

 




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: D4T4 Solutions PLC via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Arcoma presenterar på Redeye Life Science Day den 21:a november16.11.2018 12:53Pressmeddelande

16 November Den 21 november presenterar Jesper Söderqvist, VD på Arcoma, den senaste utvecklingen i Arcoma på Haymarket by Scandic i Stockholm. Presentationen "Arcoma, ett tillväxtbolag i en växande marknad" hålls klockan 13:00 och kan följas i livesändning på redeye.se/live/lsday-2018. Presentationen kommer även i efterhand att finnas tillgänglig på www.redeye.se/live/ls-day-2018 samt på Bolagets sida i Redeye Universe (redeye.se/company/Arcoma) Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalitet och avancerad teknik. Arcomas produkter erbjuder den senaste digitala bildtekniken kombinerat med tekniskt avancerade rörliga positioneringssystem, vilket tillsammans med ergonomisk skandinavisk design, erbjuder kunden kompletta, konfigurerbara och funktionella digitala röntgensystem. Bolagets produkter säljs via återförsäljare samt via OEM-kunder och det finns idag över 3 500 av Arcomas röntgensystem installerade

Iconovo: kundprojekt blir framflyttat tre till sex månader8.11.2018 15:45Pressmeddelande

Fortsatt arbete med ett av Iconovos pågående kundprojekt kommer att flyttas fram tre till sex månader. Projektet avser utveckling av produkt anpassad för kund som ska svara för produktion och marknadslansering. Det aktuella arbetet var planerat att ske under fjärde kvartalet men beräknas ske under nästa år, och detta påverkar Iconovos omsättning under 2018 negativt med cirka 2 miljoner kronor. Orsaken är att kunden har beslutat att genomföra en mindre klinisk studie för att verifiera produkten innan nästa steg tas vilken omfattar investeringar i betydande mångmiljonbelopp i produktionskapacitet, baserat på Iconovos utveckling. Studien görs för kundens egna räkning och är inte villkorad av tillsynsmyndigheter. "Detta påverkar vårt resultat på kort sikt, men det faktum att kunden har beslutat att göra en betydande investering i faktisk produktion betyder att vi med stor säkerhet kan se fram emot licensintäkter under en lång tidsrymd framöver i samband med att produkten lanseras på markna

Stillfront Group AB: Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 20187.11.2018 14:34Pressmeddelande

PRESSMEDDELANDE 7 november 2018 Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 2018 Stillfront Groups kvartalsrapport för det tredje kvartalet 2018 kommer att publiceras klockan 07.00 den 22 november 2018. En webbsänd telefonkonferens kommer att hållas klockan 10.00 samma dag där Jörgen Larsson, VD och Sten Wranne, CFO, kommenterar resultatet. Presentationen och rapporten kommer efter presentationen att finnas tillgänglig på www.stillfront.com Webbsändningen nås på adressen: https://tv.streamfabriken.com/stillfront-q3-2018 För att delta via telefon, vänligen ring: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FÖR YTTERLIGARE INFORMATION, VÄNLIGEN KONTAKTA: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com OM STILLFRONT Stillfront är en oberoende utvecklare, förläggare och distributör av digitala spel - med visionen att bli en ledande indie-spelutvecklare och förläggare. Stillfront är verksamt genom tio näst intill självständiga dotte

Stillfront Group AB: Invitation to Stillfront Group Q3 presentation7.11.2018 14:34Pressmeddelande

Invitation to Stillfront Group Q3 presentation Stillfront Group interim report for the third quarter 2018 will be published at 07.00 CET on 22 November 2018. A presentation of the report will be held the same day at 10.00 CET via telephone conference or audiocast where Jörgen Larsson, CEO and CFO Sten Wranne are to comment on the report. The presentation can be viewed live at https://tv.streamfabriken.com/stillfront-q3-2018 To participate via phone please call: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FOR FURTHER INFORMATION, PLEASE CONTACT: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com ABOUT STILLFRONT Stillfront is a group of independent creators, publishers and distributors of digital games - with a vision to become the leading group of indie game creators and publishers. Stillfront operates through ten near-autonomous subsidiaries: Bytro Labs in Germany, Coldwood Interactive in Sweden, Power Challenge in the UK and Sweden, Dorado Online Games

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum